Click here for the article published by The Wall Street Journal.
Robert Nelson has invested hundreds of millions in Altos Labs, a biotech company working on ways to rejuvenate cells and eliminate disease
Disclaimer: The content of this article has not been checked or verified. Proceed at your own risk.
